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Abstract
Neural stem cells (NSCs) in the adult mouse hippocampus occur in a speciﬁc neurogenic niche, where a multitude of extracellular
signaling molecules converges to regulate NSC proliferation as well as fate and functional integration. However, the underlying
mechanisms how NSCs react to extrinsic signals and convert them to intracellular responses still remains elusive. NSCs contain a
functional endocannabinoid system, including the cannabinoid type-1 receptor (CB1). To decipher whether CB1 regulates adult
neurogenesis directly or indirectly in vivo, we performed NSC-speciﬁc conditional inactivation of CB1 by using triple-transgenic
mice. Here, we show that lack of CB1 in NSCs is sufﬁcient to decrease proliferation of the stem cell pool, which consequently
leads to a reduction in the number of newborn neurons. Furthermore, neuronal differentiation was compromised at the level of
dendritic maturation pointing towards a postsynaptic role of CB1 in vivo. Deteriorated neurogenesis in NSC-speciﬁc CB1 knock-
outs additionally resulted in reduced long-term potentiation in the hippocampal formation. The observed cellular and
physiological alterations led to decreased short-term spatial memory and increased depression-like behavior. These results
demonstrate that CB1 expressed in NSCs and their progeny controls neurogenesis in adult mice to regulate the NSC stem cell
pool, dendritic morphology, activity-dependent plasticity, and behavior.
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Adult-born neurons are continuously generated in two zones of
the mouse brain throughout life, in the subgranular zone (SGZ)
of the dentate gyrus (DG) and in the subventricular zone (SVZ)
of the lateral ventricle (Aimone et al. 2014; Bond et al. 2015).
Newborn neurons in the SGZ migrate into the granule cell layer
and are incorporated in the hippocampal circuitry to regulate
multiple physiological functions (Dupret et al. 2007; Danielson
et al. 2016; Anacker and Hen 2017; Toda et al. 2018), and fur-
thermore, contribute to hippocampal plasticity (Toda and Gage
2018). Whether adult neurogenesis occurs in all mammals
including humans is still under debate. Absence of adult neuro-
genesis was shown in cetaceans (Patzke et al. 2015).
Additionally, three very recent publications were unable to
demonstrate robust generation of newborn neurons in the
adult human brain (Dennis et al. 2016; Cipriani et al. 2018;
Sorrells et al. 2018), though another publication in 2018 came to
the opposite conclusion and reported lifelong neurogenesis in
humans (Boldrini et al. 2018), supporting evidences from earlier
publications (reviewed in Kempermann et al. 2018).
The process of neurogenesis in the adult mouse brain is com-
prised of slowly dividing radial glial cells (type-1 cells) and the
rapidly amplifying neural progenitor cells (NPCs, type-2 cells),
which differentiate into neuroblasts and later into mature gran-
ule neurons with dendritic arborizations toward the molecular
layer of the DG, and axonal projections toward the CA3 region
(Toni and Schinder 2015; Pilz et al. 2018). Hippocampal adult neu-
rogenesis is tightly controlled by the unique local microenviron-
ment of the SGZ, where a multitude of signals converge to
dynamically modulate the neural stem cell (NSC) niche.
Although many extracellular signals, such as neurotrophins, neu-
rotransmitters, cytokines, and hormones, are known to be
involved in the regulation of NPC proliferation and differentiation
(Mu et al. 2010; Goncalves et al. 2016), the precise extrinsic and
intrinsic mechanisms involved in proliferation and cell fate
determination remain to be fully elucidated. Many growth fac-
tors, such as epidermal growth factor (EGF) and basic ﬁbroblast
growth factor (bFGF), act as key regulators of NSC proliferation
and differentiation (Temple 2001; Kempermann 2011). In addi-
tion, a variety of signals participate in the regulation of NPC dif-
ferentiation to either neurogenesis or gliogenesis (Bond et al.
2015). In the past years, growing evidence has evolved that the
endocannabinoids N-arachidonoylethanolamine (anandamide)
and 2-arachidonoylglycerol (2-AG) as well as exogenous cannabi-
noids affect adult neurogenesis (Jiang et al. 2005; Marchalant
et al. 2009; Wolf et al. 2010; Campos et al. 2013). Furthermore,
modulation of endocannabinoid synthesis by either knocking out
or inhibiting diacylglycerol lipase (DAGL) leads to a reduction of
neurogenesis in both adult neurogenic zones (Gao et al. 2010;
Oudin, Gajendra, et al. 2011). It has been demonstrated that adult
NSCs contain a functional endocannabinoid system, which
includes, besides the endocannabinoid synthesizing and degrad-
ing enzymes, the cannabinoid type-1 receptor (CB1) (Aguado
et al. 2005; Galve-Roperh et al. 2007). CB1 is one of the most abun-
dant G-protein coupled receptors in the brain with high expres-
sion levels in multiple neuronal subtypes (Marsicano and Kuner
2008). However, mature granule neurons in the dentate gyrus do
not express CB1 (Monory et al. 2006), which could suggest that
CB1 serves as an important regulator of adult NSCs and NPCs.
Generally, CB1 has multiple functions, which are the inhibition of
neurotransmitter release and the activation of different intracel-
lular signaling cascades (Araque et al. 2017; Kendall and
Yudowski 2017). Activation of CB1 leads to different cellular func-
tions such as neuroprotection during epilepsy (Marsicano et al.
2003), cell lineage commitment (Bertrand et al. 2002), migration
(Mulder et al. 2008), survival (Galve-Roperh et al. 2008; Díaz-
Alonso et al. 2017), and neurite outgrowth (Berghuis et al. 2007) of
developing neural cells. The observed effects of activated CB1
could be either explained via action on cells outside of the NSC
lineage (indirect) through its modulatory role on neurotransmitter
release, or direct via action on cells within the NSC lineage (i.e.,
NSCs, precursors, neuroblasts, neurons). Signaling through the
PI3K/Akt and ERK pathways, downstream targets could involve
the mammalian target of rapamycin complex 1 (mTORC1) and the
cAMP response element-binding protein (CREB), which are central
regulators of immediate early genes, such as c-fos, c-jun, zif268,
and brain-derived neurotrophic factor (BDNF) (Pagotto et al. 2006;
D’Souza et al. 2009; Gowran et al. 2011; Prenderville et al. 2015).
Intriguingly, CB1-deﬁcient mice display reduced adult hip-
pocampal neural precursor proliferation and decreased astro-
glial differentiation in vitro and in vivo (Jin et al. 2004; Aguado
et al. 2006; Dubreucq et al. 2010). However, it is still unclear
whether CB1 regulates adult NSCs through direct signaling in
NSCs or an indirect mechanism via surrounding cells, e.g., by
modulated neurotransmitter release from glutamatergic and/or
GABAergic neurons, whereas both effects are not mutually
exclusive. Indeed, neurotransmitters have been shown to affect
the process of adult neurogenesis, and although the role of glu-
tamate is less clearly delineated (Prenderville et al. 2015), the
ability of GABA to reduce proliferative capacity is well estab-
lished (Song et al. 2013).
To better understand the mechanism of CB1 in adult neuro-
genesis, we conditionally knocked-out CB1 (encoded by CNR1)
in adult NSCs. So far, only a few studies were able to show a
direct receptor gene function in regulating SGZ neurogenesis.
One of the few examples is the conditional deletion of the FGF
receptor FGFR1 (Zhao et al. 2007) impairing NPC proliferation in
the DG of adult mice. Furthermore, the study of Bergami and
colleagues (Bergami et al. 2008) demonstrated that conditional
NPC-speciﬁc deletion of TrkB led to compromised dendritic
development and survival capacity of immature neurons, and
BDNF-TrkB signaling has been shown to be imperative for hip-
pocampal NSC proliferation in mice (Li et al. 2008). By using an
inducible nestin-Cre mouse line we assessed the impact of NSC
lineage-speciﬁc CB1 deletion on proliferation and differentia-
tion of adult hippocampal NSCs, long-term potentiation, and
hippocampus-dependent behavior. Our present study shows
that proliferation of adult NSCs critically depends on activation
of CB1 within the NSC lineage itself in vivo and reveals its
remarkable impact on functional connectivity and involvement
in behavior.
Material and methods
Animals
CB1-ﬂoxed (Marsicano et al. 2003), ROSA-stop-YFP (Srinivas
et al. 2001) and nestin-CreERT2 (Corsini et al. 2009) mice were
bred, in order to ﬁnally generate nes-CB1ko/ko mice (containing
homozygous CB1-ﬂoxed/ﬂoxed alleles, homozygous ROSA-
stop-YFP alleles, heterozygous nestin-CreERT2 allele) and con-
trol CB1wt/wt mice (containing homozygous CB1-wt/wt alleles,
homozygous ROSA-stop-YFP alleles, heterozygous nestin-
CreERT2 allele) (in C57BL/6 N background). Eight week old male
mice were used for the study. Animals were single housed in a
temperature- and humidity-controlled room with a 12 h light
dark cycle (lights on 5 am - 5 pm) and had access to food and
water ad libitum. All experiments were carried out in accor-
dance with the European Community’s Council Directive of 22
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September 2010 (2010/63EU) and were approved by the local
animal care committee (Landesuntersuchungsamt Koblenz,
permit number G 13-1-093 and G 16-1-018). Experimenters were
blind to the genotype of mice.
Tamoxifen and BrdU administration
Eight weeks old nes-CB1ko/ko and CB1wt/wt mice were admin-
istered tamoxifen (TAM) at 60mg/kg/d for 5 days (intraperito-
neal (i.p.); dissolved in 10% EtOH/90% sunﬂower oil). To
examine the survival, proliferation, and differentiation of tar-
geted cells, mice were injected for 5 days with bromodeoxyuri-
dine (BrdU, 50mg/kg/d) 23 days after TAM treatment. Mice
were killed either one or 28 days after BrdU injections.
Production of recombinant lentivirus
High titer lentiviral particles were produced in 293LTV cells by
transient transfection with calcium phosphate of transfer vec-
tor HS1-Cre (Suh et al., 2007), second-generation packaging con-
struct pCMV-deltaR8.91, and vesicular stomatitis virus
envelope-expressing construct pMD2.G. 72 h after transfection,
the supernatant was collected and puriﬁed by ultracentrifuga-
tion. The pellet was resuspended in PBS and aliquots stored at
−80°C until use. The amount of transducing units was deter-
mined by diluting serially concentrated lentivirus into cell
medium, plating and growing for 3 days. Cells were immunocy-
tochemically stained and clones per sample were counted.
Measurement of p24 concentration was carried out with the
HIV-1 p24 ELISA assay (BioCat, Heidelberg, Germany).
Lentivirus vector administration
Adult mice were anesthetized by an i.p. injection of a combina-
tion of fentanyl (0.05 mg/kg), midazolam (5 mg/kg), and mede-
tomidin (0.5 mg/kg). Mice were positioned in a stereotactic
apparatus and kept on an animal heating pad to control body
temperature during surgery. The scalp was cut open in rostro-
caudal direction and lidocaine spray was applied on the skull
and the surrounding skin to reduce pain. 1 µL of the lentivirus
(1.4 × 1013 tu/mL) was injected bilaterally into the dentate
gyrus at the following coordinates from bregma: −2.0 mm ante-
riorposterior, ±2.0 mm mediolateral, −2.0 dorsoventral. The
virus was applied using a microprocessor controlled mini-
pump with a 34G beveled NanoFil needle at a ﬂow rate of 200
nL/min. The injection needle was left in place for additional 5
min and then slowly removed. After sewing the scalp, anesthe-
sia was antagonized by intraperitoneal injection of ﬂumazenil
(0.5 mg/kg), naloxon (1.2 mg/kg) and atipamezol (2.5 mg/kg).
Additionally, mice received a subcutaneous injection of bupre-
norphine (0.05 mg/kg) to reduce pain and 1 ml of 0.9% saline to
compensate ﬂuid loss during and after surgery. The mice were
returned to their home cages, which were kept on a heating
plate at 37°C overnight.
Immunohistochemistry
For immunohistochemistry, mice were perfused transcardially
with 4% paraformaldehyde (PFA), brains were removed, post-
ﬁxed overnight in 4% PFA and treated with 30% sucrose for
48 h. Then, brains were sectioned 30 μm thick in coronal plane
and stored at 4 °C in cryoprotection solution until use.
Sections were blocked in phosphate buffered saline (PBS)
containing 5% normal donkey serum (NDS), 2.5% bovine serum
albumin (BSA) and 0.3% Triton X-100 (TX) for 90min and
incubated with the respective primary antibody in PBS contain-
ing 1% NDS, 0.1% BSA and 0.3% TX overnight. To double-stain
with an anti-BrdU antibody, slides were ﬁxed again for 15min
in 4% PFA to stabilize antigen-ﬁrst primary antibody com-
plexes. Sections were then incubated in 1N HCl for 1 h at 37 °C
to denature DNA, followed by 3 × 5min washes with TBS. Brain
slices were then blocked in tris buffered saline (TBS) with 1%
NDS, 0.1% BSA and 0.3% TX for 90min and incubated with pri-
mary antibodies in blocking buffer overnight at 4 °C. On the
next day, appropriate secondary antibodies were applied for
2 h. To visualize cell nuclei in non-BrdU treated sections, brain
slices were incubated with 4′,6-diamidino-2-phenylindole
(DAPI) for 5min, washed with PBS and mounted with Mowiol
onto slides.
The following primary antibodies were used: rat anti-BrdU
(1:100, Abcam), rabbit anti-GFP (1:500, kind gift of Matthias
Klugman, Sydney, Australia), chicken anti-GFP (1:1000, Aves
Labs), rabbit anti-RFP (1:500, Rockland), guinea pig anti-DCX
(1:500, Merck), mouse anti-NeuN (1:500, Abcam), rabbit anti-
S100b (1:500, Abcam), rabbit anti-CB1 (1:1000, Immunogenes),
rabbit anti-CALB (1:5000, Swant), rabbit anti-cleaved Casp3
(1:200, Cell Signaling), mouse anti-GAD67 (1:500, Millipore).
Mouse anti-CALR antibody (1:1000, Millipore) was used after
antigen retrieval at 98 °C for 15min in sodium citrate buffer
(10mM sodium citrate, 0.05% Tween 20, pH 6.0).
The respective secondary antibodies were applied: anti-
rabbit IgG AlexaFluor488, goat anti-rabbit, goat anti-guinea pig,
goat anti-rat AlexaFluor546 and goat anti-rabbit or anti-rat
AlexaFluor647 (all 1:1000, Invitrogen).
Microscopic analysis of histology
Morphological and immunohistochemical analysis were per-
formed with brains of naïve animals, which did not undergo
behavioral tests before.
Cells were quantiﬁed in the hippocampus of each animal
based on the Cavalieri principle of stereology. Every sixth atlas-
matched, coronal hippocampal section located between 1.2 and
2.3mm posterior to bregma, which comprises the dorsal and
mid-dorsoventral part of the hippocampus, was used. The
number of cells was normalized to the area of the dentate
gyrus of each 30 μm section, followed by the determination of
the total positive cell number in the 1080 μm analyzed region
per animal. This was achieved by multiplying the counted cell
number in each analyzed 30 μm section with 6 and then sum-
marizing the total cell number per 180 μm region. Accordingly,
the SVZ was analyzed (Supplementary data) comprising the
region between 1.18 anterior to 0.02mm posterior to the
bregma.
Slides were observed under a Leica DM5500 ﬂuorescence
microscope or a Zeiss Axiovert LSM 710 laser scanning confocal
microscope. For laser scanning confocal microscopy, z-stacks
with optical sections of 1 μm were recorded.
YFP-positive cell numbers and co-localization with speciﬁc
markers were counted in every sixth section (180 μm apart) and
calculated based on the Cavalieri principle of stereology for the
DG. For each marker four to six animals were analyzed.
Dendritic morphology and axonal growth
For dendritic analysis, animals were injected with TAM for 5
days. On the next day 1 μl of retrovirus CAG-DsRedExpress2
(Deshpande et al. 2013) with a titer in the range of 6.6 × 1010 to
2 × 1012 tu/ml (kindly provided by M. Götz, Munich) was injected
CB1 receptor in adult neurogenesis Zimmermann et al. | 3
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bilaterally into the dentate gyrus. Animals were perfused 28
days post infection (dpi), and brains were cut in 100 μm thick
sections. Sections were immunostained with anti-RFP, anti-
GFP, and anti-NeuN antibodies.
Z-series at 1.5 μm intervals were acquired by confocal
microscopy with a 40x oil objective. The signal from immuno-
reactive intact neuronal dendrites was traced with Fiji by the
NeuronJ plugin. The length of dendritic arbors was analyzed,
and Sholl analysis was performed with the Sholl analysis
plugin for Fiji. Dendritic spines were revealed by a 100x oil
objective and z-stacks were acquired at 0.5 μm intervals in a
total of 3–6 μm thickness. The number of spines was counted
manually on the 2D maximum intensity projections, and spine
density was calculated by dividing the number of dendritic pro-
trusions by the total length of the analyzed segment (10–47 μm
length).
For analysis of axonal growth, sections were photographed
with the Perkin Elmer Opera Phenix HCS system in 1 μm
z-intervals (total thickness 100 μm) with a 20x water objective.
Maximum intensity projections were used to score axonal
length by tracing ﬁbers from the dentate to the end of axons in
the CA3 region as previously reported (Zhao et al. 2006;
Bergami et al. 2008). Measurement was performed by Fiji.
Electrophysiology
In vitro extracellular recordings were performed on acute hippo-
campal slices of wild-type control (CB1wt/wt) and CB1 KO ani-
mals (nes-CB1ko/ko). Mice were injected with Tamoxifen for ﬁve
consecutive days at an age of eight weeks. Electrophysiological
recordings were performed 4–6 weeks later. In-between animals
were housed in a temperature- and humidity-controlled room
with a 12h light-dark cycle and had access to food and water ad
libitum.
Electrophysiology: medial perforant path – DG
Transverse hippocampal slices (300 μm) were prepared from the
dorsal hippocampus of 12–14 week old mice. Slices were incu-
bated in oxygenated sucrose-containing artiﬁcial cerebrospinal
ﬂuid (ACSF) for 2 to 3 h and then transferred into oxygenated
ACSF used for recordings. Composition of sucrose-containing
ACSF: 85mM NaCl, 75mM sucrose, 2.5mM KCl, 25mM glucose,
1.25 NaH2PO4, four MgCl2, 0.5 CaCl2, and 24 NaHCO3; composition
of recording ACSF: 126mM NaCl, 2.5mM KCl, 26mM NaHCO3,
2mM CaCl2, 2mM MgCl2, 1.25mM NaH2PO4, and 10mM glucose.
As speciﬁed in the results, in a subset of experiments, ifenprodil
(3 μM; Tocris Bioscience) or picrotoxin (50 μM, Sigma-Aldrich)
were added to the recording ACSF 20min before to start the
recordings and maintained throughout the recording time.
To elicit ﬁeld excitatory postsynaptic potentials (fEPSPs) in
the DG, a concentric bipolar stimulating electrode was placed
in in the medial molecular layer of the upper blade of the DG to
stimulate the afferent ﬁbers of the medial perforant path (MPP).
Input/output curves were obtained and the stimulation inten-
sity producing ~50% of maximal response was used for test
pulses and LTP induction. Baseline fEPSP were recorded for
20min with a frequency of one test stimulus every 30 s. LTP
was induced by tetanic stimulation that consisted of four trains
of 100 Hz lasting 500ms each, repeated every 20 s. After LTP
induction, fEPSP were recorded every 30 s for additional 60min.
Slices were visualized with an upright microscope (Olympus;
BX61WI) with infrared–differential interference contrast (IR-
DIC) optics. All electrophysiological recordings were done at
33 °C. MultiClamp700B ampliﬁer (Molecular Devices) was used
for recordings. Signals were ﬁltered at 3 kHz using a Bessel ﬁlter
and digitized at 10 kHz with a Digidata 1440 A analog–digital
interface (Molecular Devices). The recorded traces were ana-
lyzed using Clampﬁt 10.2 (Molecular Devices).
Electrophysiology: Schaffer collaterals – CA1
Acute hippocampal transversal slices were prepared from indi-
viduals at an age of 12 weeks, four weeks after TAM treatment.
Mice were anesthetized with isoﬂurane and decapitated. The
brain was removed and quickly transferred into ice-cold carbo-
genated (95% O2, 5% CO2) ACSF containing 125.0mM NaCl,
2.0mM KCl, 1.25mM NaH2PO4, 2.0mM MgCl2, 26.0mM NaHCO3,
2.0mM CaCl2, 25.0mM glucose. The hippocampus was sec-
tioned into 400 μm thick transversal slices with a vibrating
microtome (Leica, VT1200S). Slices were maintained in carboge-
nated ACSF at room temperature for at least 1.5 h before being
transferred into a submerged recording chamber.
Slices were placed in a submerged recording chamber and
perfused with carbogenated ACSF (32 °C; (125.0mM NaCl,
2.0mM KCl, 1.25mM NaH2PO4, 1.0mM MgCl2, 26.0mM NaHCO3,
2.0mM CaCl2, 25.0mM glucose)) at a rate of 1.2 to 1.5ml/min.
fEPSPs were recorded in stratum radiatum of the CA1 region
with a borosilicate glass micropipette (resistance 2–5 Ω) ﬁlled
with 3M NaCl at a depth of 150–200 μm. Monopolar tungsten
electrodes were used for stimulating the Schaffer collaterals at
a frequency of 0.1 Hz. Stimulation intensity was adjusted to
40% of maximum fEPSP slope for 20min baseline recording.
LTP was induced by applying theta-burst stimulation (TBS: 10
trains of four pulses at 100Hz in a 200ms interval, repeated 3
times).
Basal synaptic transmission properties were analyzed via
input-output measurements and short-term plasticity was
examined via paired pulse facilitation. The IO- measurements
were performed either by application of a deﬁned current val-
ues (25–- 250 μA) or by adjusting the stimulus intensity to cer-
tain ﬁber volley amplitudes (0.1–0.7mV). PPF was performed by
applying a pair of two closely spaced stimuli in different inter-
stimulus-intervals (ISI) ranging from 10 to 160ms.
Behavioral assays
Bodyweight was measured once per week to observe any effect
of TAM treatment on the overall health of animals. Animals
were separated and single-housed one week before the start of
behavioral assays. All behavioral tests were performed during
the light phase of the cycle, starting at 8 am.
Open ﬁeld test
Mice were placed in the center of a white box (40 × 40 × 40 cm3)
at 90 lux and their behavior was video recorded for 15min and
tracked using EthoVision XT. The distance moved was
analyzed.
Light/dark box test
The experimental setup comprises an open, white, brightly-
illuminated (100 lux at entry site) compartment (40 × 27 ×
40 cm3) and a closed, black, dark compartment (40 × 13 ×
40 cm3). Mice were placed in the dark compartment and
allowed to explore the arena freely for 5min. The entries and
the time spent in the lit compartment were used as parameters
to assess aversive behavior (Chambers et al. 2004).
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Spatial object recognition test
The test was performed in a Y-maze (three arms (30 × 10 cm) at
120° from each other made of gray PVC) at 10 lux in the center
of the maze. The mazes were surrounded by spatial extra-maze
cues (white paper with black shapes) and taped intra-maze
cues. Mice were placed in the center of the Y-maze. Animals
were habituated to the empty Y-mazes for 10min on two con-
secutive days before testing. Testing consisted of acquisition,
an inter-trial interval and a retrieval trial. During the acquisi-
tion trial, mice were allowed to explore two identical copies of
an object for 10min. The objects were glass salt shakers (10 cm
height) and were placed 5 cm apart from the walls at the end of
two arms. The retrieval trial started after the 30min inter-trial
interval. During the 10min retrieval trial, one object was placed
in the empty arm of the maze (relocated object). The position
of the relocated object was counterbalanced among animals.
The acquisition and retrieval trials were video recorded and the
total distance measured with EthoVision. For each mouse, the
time spent exploring either object was manually scored during
the retrieval trial and the index of recognition was calculated:
Index of recognition (%) = (new position time/ total explora-
tion time) *100
Mice that remembered the original spatial location of the
objects were expected to explore more the relocated object,
having an index of recognition higher than 50%.
Forced swim test
The forced swim test has been shown to be a measure of behav-
ioral despair. Mice were placed in a beaker ﬁlled with water (23 °
C) and were video recorded for 5min. The behavior was ana-
lyzed manually. The immobility time was deﬁned as the dura-
tion a mouse ﬂoating in the water without struggling and
making only small movements to keep its head above the water.
Morris water maze
The Morris water maze is a spatial learning task originally
developed for rats. A large circular tank (diameter 1.20m) was
ﬁlled with water (25 ± 1 °C) and the escape platform (diameter
10 cm) was submerged 1 cm below the surface. The animals
were tracked with the Video Tracking System EthoVision XT.
During the ﬁrst 2 days, mice were trained to swim to a visible
platform (visible platform task) that was marked with a 15 cm
high black ﬂag and placed pseudo-randomly in different locations
across trials (non-spatial training). The extra-maze cues were hid-
den during these trials. After 2 days of visible platform training,
hidden platform training (spatial training) was performed.
The next following 8 days, mice had to navigate using extra-
maze cues which were placed on the walls of the testing room.
Mice were trained to ﬁnd a hidden platform which was located
at the center of the southwest quadrant of the pool. The loca-
tion of the platform was the same throughout testing. Every
day, mice performed four trials with an intertrial interval of
5min. The animals were released into the water facing the pool
wall randomly at one of four start locations and were allowed
to swim until they ﬁnd the platform, or for a maximum of 90 s.
Any mouse that failed to ﬁnd the platform within 90 s was
guided to the platform. The animal then remained on the plat-
form for 20 s before being removed from the pool. The day after
completion of the hidden platform training, a probe trial was
conducted in order to determine whether the mice had devel-
oped a spatial preference for the former platform quadrant.
The platform was removed from the pool and the mice were
allowed to swim freely for 90 s.
Statistical analysis
Data are represented as the mean ± standard error of the mean
(SEM). Statistical analysis was done using GraphPad Prism 4
(GraphPad Software Inc, La Jolla, CA, USA) and IBM SPSS
Statistics 22 v software (IBM Corporation, Armonk, NY, USA).
Unless otherwise speciﬁed, data were analyzed using two-
tailed unpaired Student’s t-test. For Sholl analysis, repeated
measures ANOVA followed by post hoc Bonferroni test for
group comparison was used. The p-value used to determine
signiﬁcance was P < 0.05.
Results
Conditional deletion of CB1 from adult NSCs
To assess the direct inﬂuence of CB1 on regulating adult neurogen-
esis in vivo, we generated a triple-transgenic mouse line (Fig. 1A)
by crossbreeding mice expressing a tamoxifen (TAM)-inducible
Cre-recombinase under the NSC-speciﬁc nestin promoter and
enhancer with ﬂoxed CB1 mice. To visualize recombined cells, the
offspring was additionally crossed with the reporter mouse line
ROSA26-ﬂoxed-stop-YFP. TAM treatment led to Cre-mediated exci-
sion of the ﬂoxed-stop cassette inducing YFP expression, and to
Cre-mediated deletion of CB1, obtaining nes-CB1ko/ko. Control
mice are called CB1wt/wt, containing Cre-mediated YFP expression
after TAM treatment, but wild-type CB1 alleles. Recombination
efﬁciency in CB1 and ROSA genomic loci was similar, as evaluated
by genomic PCR analyzes in clonally-derived single DG-derived
neurospheres from TAM treated mice (Supplementary Fig. 1). In
further experiments, mice were injected with TAM at eight weeks
of age and used for analyzes 28 or 56 days later (Fig. 1B).
Recombination and expression of YFP occurred speciﬁcally in both
neurogenic regions, in the SVZ (Fig. 1C) and the SGZ of the DG
(Fig. 1D). In order to exclude unwanted ectopic recombination in
GABAergic interneurons, we veriﬁed that the pool of forebrain
CB1-expressing interneurons was unchanged in nes-CB1ko/ko as
compared to CB1wt/wt control mice (Supplementary Fig. 2).
Quantiﬁcation of YFP reporter-positive cells in the SGZ
(Fig. 1E) showed that at 28 days post TAM treatment (dptm) in
CB1wt/wt mice 11 700 ± 534 cells were YFP-positive.
Signiﬁcantly less (P = 0.007) YFP-positive cells were found in
the SGZ of nes-CB1ko/ko mice (7823 ± 903). At 56 dptm, the
number of YFP-positive cells was still reduced (P = 0.048) in
nes-CB1ko/ko mice (10 600 ± 1375) compared to CB1wt/wt mice
(14 660 ± 887). When performing a two-way analysis of variance
(ANOVA) for time and genotype, we found a signiﬁcant increase
of YFP-positive cells by 56 dptm compared to 28 dptm (P =
0.009), and a signiﬁcant genotype difference (P = 0.001). No
interaction between time and genotype was observed, indicat-
ing that independent of the genotype an increase of labeled
cells was found at the later time point.
To conﬁrm that CB1 was deleted from YFP-positive cells, we
immunostained sections from CB1wt/wt and nes-CB1ko/ko
with YFP and CB1 speciﬁc antibodies (Fig. 1F). CB1 was not
detected anymore in recombined YFP-positive cells of nes-
CB1ko/ko mice.
Deletion of CB1 reduces proliferation capacity of
newborn cells
Since nes-CB1ko/ko animals displayed a decreased number of
YFP-positive cells, we investigated the maturation stage of the
cells by quantifying YFP-positive cells co-expressing cell type-
speciﬁc antigens at 28 dptm and 56 dptm. At 23 dptm, we
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injected BrdU for ﬁve consecutive days to follow the prolifera-
tion and fate of recombined cells (Fig. 2A).
At 28 dptm, we found recombined YFP cells either positive
for doublecortin (DCX), NeuN or S100b as assessed by immunos-
taining in both genotypes (Fig. 2B). Furthermore, a population of
YFP-positive cells was marked by anti-BrdU immunoreactivity
(Fig. 2C). Four weeks later (56 dptm), YFP cells still co-expressed
the aforementioned markers (Fig. 2D). When we quantiﬁed the
co-localizing cells, we found at 28 dptm 6424 ± 427 cells in CB1
wt/wt mice expressing the marker of developing neurons DCX,
whereas 4388 ± 620 cells in nes-CB1ko/ko were positive for DCX,
representing a decreased (P = 0.035) pool of neuroblasts. At this
stage, 2178 ± 450 cells in CB1wt/wt mice were positive for the
marker NeuN, but only 716 ± 250 cells in nes-CB1ko/ko mice,
demonstrating additionally a signiﬁcantly decreased (P = 0.047)
number of mature neurons (Fig. 2E). Also, YFP cells positive for
S100b, marking the astroglial lineage, were signiﬁcantly reduced
at 28 dptm in nes-CB1ko/ko mice (P = 0.021), with 1800 ± 292
cells as compared to 2890 ± 24 cells in CB1wt/wt animals. At 56
dptm, the YFP/S100b-positive astrocytic population was much
smaller (546 ± 81 cells in CB1wt/wt, 408 ± 79 cells nes-CB1ko/ko
mice), without signiﬁcant genotype differences (P = 0.269), but
same trend as at 28 dptm.
In contrast to the astrocytic YFP cells, the pool of both neuro-
nal populations (DCX+ and NeuN+) increased in wild-type and
mutant animals at 56 dptm. 6992 ± 681 YFP-positive cells were
positive for DCX in the CB1wt/wt animals, while only 4358 ± 587
cells were positive for DCX in nes-CB1ko/ko mice (P = 0.026).
Furthermore, nes-CB1ko/ko animals showed a decreased (P =
0.029) number of YFP/NeuN double positive cells (3773 ± 84)
compared to CB1wt/wt mice (6828 ± 851) (Fig. 2E). Furthermore,
we addressed the stage-speciﬁc markers calretinin (CALR),
which generally starts to get expressed 14 days after neuron
birth in the SGZ, and calbindin (CALB), starting to be expressed
Figure 1. (A) Scheme of the strategy for conditional deletion of CB1 from NSCs and genetic tagging of NSC with YFP in vivo (using nes-CreERT2, expressing tamoxifen-
inducible Cre under the control of nestin promoter/enhancer elements, P/E), obtaining nes-CB1ko/ko. The respective controls (CB1wt/wt) contain the wild-type CB1
alleles, but are YFP tagged. (B) Time course of experiment. Mice were perfused at 28 days post tamoxifen-induced recombination (dptm) or 56 dptm. (C) Recombined
cells express YFP (green) and are present in the subventricular zone (SVZ) and (D) in the subgranular zone (SGZ) of the dentate gyrus (DG). (E) Quantiﬁcation of YFP-
positive cells in the DG revealed a signiﬁcant decrease in nes-CB1ko/ko mice as compared with CB1wt/wt at 28 dptm and 56 dptm. n = 4 animals/group, **P < 0.01, *P <
0.05, two-tailed unpaired Student’s t-test. Data are represented as mean ± SEM. (F) Representative confocal images including z-stacks display co-localization of
recombined YFP cells (green) and CB1 expression (red) in CB1wt/wt mice, whereas nes-CB1ko/ko mice show a lack of CB1 expression in recombined YFP cells (arrow-
heads indicate corresponding points in the orthogonal planes). DAPI, blue. Scale bar, 100 μm. Cortex (Cx); Striatum (Str); granule cell layer (GCL), molecular layer (ML).
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Figure 2. (A) Schedule of experiment. Mice were injected with BrdU for ﬁve d at 23 dptm and were analyzed at 28 dptm and at 56 dptm, respectively. (B) Maximum
intensity projections of z-stacks show YFP-positive cells expressing DCX, NeuN or S100b at 28 dptm. (C) Maximum intensity projections of z-stacks show YFP expres-
sing cells positive for BrdU at 28 dptm (ﬁlled arrowhead: colocalizing cell). (D) Triple co-localization (ﬁlled arrowhead) at 56 dptm (with magniﬁcation in the quadrant),
empty arrowhead: positive YFP/BrdU cell. (E) Quantiﬁcation of YFP-positive cells co-localizating with the neuronal and astrocytic markers. Deletion of CB1 reduces
the YFP/DCX and YFP/NeuN population at 28 dptm and 56 dptm. YFP/S100b cells were signiﬁcantly reduced only at 28 dptm. n = 5 (28 dptm S100b), n = 3 (28 dptm
DCX), n = 4 (28 dptm NeuN), n = 4 (56 dptm S100b), n = 4 (56 dptm DCX), n = 4 (56 dptm NeuN) animals/group *P < 0.05, **P < 0.01, two-tailed unpaired Student’s t-test.
(F) Nes-CB1ko/ko animals displayed a signiﬁcantly reduced number of newborn cells, as assessed by co-localization of YFP with BrdU. n = 5 (28 dptm CB1wt/wt), n = 6
(28 dptm nes-CB1ko/ko), n = 4 (56 dptm CB1wt/wt), n = 4 (28 dptm nes-CB1ko/ko) animals/group; *P < 0.05, **P < 0.01, two-tailed unpaired Student’s t-test.
(G) Differentiation of BrdU labeled cells into the neuronal (NeuN) or astroglial (S100b) lineage is not affected at 56 dptm. N = 4 animals/group, two-tailed unpaired
Student’s t-test, n.s. not signiﬁcant. Data represent mean ± SEM. Scale bar, 50 μm. Subgranular zone (SGZ), granule cell layer (GCL), molecular layer (ML).
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approximately after one month (Zhao et al. 2008). When analyz-
ing CALR at 28 dptm and CALB at 56 dptm, we also observed
approximately half as many YFP co-expressing cells in nes-
CB1ko/ko mice with these two maturation markers (Fig. 3A, B).
At 28 dptm, 13.79 ± 1.54% of YFP-positive cells were positive for
CALR in CB1wt/wt animals, whereas nes-CB1ko/ko animals dis-
played only 7.752 ± 0.35% double positive cells. At 56 dptm, 41.89
± 2.61% cells were CALB/YFP-positive in CB1wt/wt and 25.71 ±
1.51% in nes-CB1ko/ko animals.
In order to generally analyze at which maturation state neu-
ronal progenitors loose CB1 expression, as mature granule cells
are devoid of it (Monory et al. 2006), we performed double FISH
for CB1 and CALR, and CALB, respectively. ISH experiments
revealed that CB1 is still expressed at the stage of CALR expres-
sion in developing newborn neurons (Supplementary Fig. 3)
and is absent on further differentiated CALB-positive cells in
the subgranular zone (Supplementary Fig. 4).
Since the deletion of CB1 from NSCs led to a decreased pool
of astrocytes, neuroblasts, and neurons, we assessed the prolif-
eration rate of the recombined cells (Fig. 2F). We found that in
CB1wt/wt mice 900 ± 34 cells were YFP/BrdU-positive and only
586 ± 81 in nes-CB1ko/ko, representing a signiﬁcant smaller
Figure 3. (A) Maximum intensity projections of z-stacks showing YFP- positive cells expressing calretinin (CALR) at 28 dptm (arrowhead: co-localizing cell) and calbin-
din (CALB) at 56 dptm. Scale bar, 20 μm. (B) Quantiﬁcation of YFP cells co-localizing with the two stage-speciﬁc markers. Deletion of CB1 reduced the YFP/CALR-posi-
tive population at 28 dptm and YFP/CALB-positive population at 56 dptm. N = 4 animals/group *P < 0.05, **P < 0.01, two-tailed unpaired Student’s t-test. (C) Maximum
intensity projections of z-stacks showing YFP/BrdU-positive cells in the SVZ at 28 dptm, overview and magniﬁed area of the rectangle in the overview. Scale bar,
50 μm. (D) Quantiﬁcation of anti-BrdU and anti-YFP co-staining in the SVZ demonstrates no difference between CB1wt/wt and nes-CB1 ko/ko animals. (n = 4 for
CB1wt/wt, n = 5 for nes-CB1ko/ko). (E) Exemplary micrographs showing apoptotic cells evaluated by activated caspase-3 (Casp3) staining and YFP-positive cells in
CB1wt/wt and nes-CB1ko/ko mice at 28 dptm. Scale bar, 20 μm. (F) Averaged number of Casp3-positive cells in the DG per hippocampal section (left panel) and per-
centage of YFP/Casp3-positive cells of all Casp3-positive cells per section (right panel) at 28 dptm. N = 4 animals per genotype (CB1wt/wt: n = 13 sections; nes-CB1ko/
ko: n = 19 sections).
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Figure 4. (A) Scheme of deletion of CB1 from neural stem cells in vivo with a lentivirus containing Cre recombinase under the control of the Sox2 promoter (Sox2 P),
obtaining Sox2-CB1ko/ko. The respective controls (CB1wt/wt) contain the wild-type CB1 alleles, but are YFP tagged. (B) Experimental timeline. Eight weeks old animals
were injected with the lentivirus (LV) via stereotactic surgery. BrdU was injected i.p. for ﬁve consecutive days starting at 23 dpi, and animals were perfused at 28 dpi
and 56 dpi. (C) Representative micrographs of CB1wt/wt and Sox2-CB1ko/ko mice show recombined cells in the subgranular zone (SGZ) expressing YFP (green) after
lentivirus injection and a fraction of it co-localizing with BrdU (red) at 28 dpi and at 56 dpi. (D) Quantiﬁcation of YFP/BrdU double positive cells showed that CB1 loss
impaired signiﬁcantly cell proliferation (at 28 dpi), but maintenance of YFP/BrdU cells (at 56 dpi) is only slightly (but not signiﬁcantly) decreased upon CB1 deletion
(P = 0.060). N = 3 animals/group, *P < 0.05, two-tailed unpaired Student’s t-test, t = 2.845. (E) Exemplary micrographs of CB1wt/wt animals for YFP (green) cells co-
localizing with BrdU (red) and S100b or NeuN (blue) in the dentate gyrus at 56 dpi. Arrowheads mark triple positive cells. (F) Percentage of YFP/BrdU/marker of total
YFP/BrdU-positive cells (marker: S100b or NeuN) at 56 dpi. Differentiation into the astroglial or neuronal lineage is not affected. N = 4 (CB1wt/wt) and n = 3 (Sox2-
CB1ko/ko) animals/group, n.s. not signiﬁcant in two-tailed unpaired Student’s t-test. Values represent mean ± SEM. Scale bar, 100 μm.
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(P = 0.009) pool of proliferating cells at 28 dptm. In contrast,
NSC-speciﬁc CB1-deletion did not alter proliferation of NSCs/
NPCs in the SVZ (Fig. 3C, D). In order to test whether apoptosis
could contribute to the reduction of BrdU-positive cells in the
DG, we performed immunostaining against cleaved and there-
fore activated caspase-3. The data indicated that apoptosis was
unchanged between both genotypes (Fig. 3E, F).
BrdU-positive cells in the DG were also counted four weeks
after BrdU injection to measure their differentiation potential.
At 56 dptm, 449 ± 51 cells expressed YFP/BrdU in CB1wt/wt
mice, but only 269 ± 26 cells in nes-CB1ko/ko mice, demonstrat-
ing a signiﬁcantly (P = 0.020) smaller amount of YFP/BrdU cells
(Fig. 2F). Next, we determined the phenotype of YFP/BrdU cells
by co-immunostaining with either the neuronal marker NeuN
or the astroglial marker S100b (Fig. 2G). 91.0 ± 1.5% of YFP/BrdU
cells in CB1wt/wt mice were positive for NeuN and 85.5 ± 2.7%
in nes-CB1ko/ko mice. In contrast, 10.6 ± 0.9% of YFP/BrdU cells
in CB1wt/wt mice were positive for S100b and 10.8 ± 0.6% in
nes-CB1ko/ko mice. Thus, we found no difference between the
two genotypes in the differentiation into the neuronal or astro-
glial lineage. Taken together, our results indicate that CB1 regu-
lates the proliferation capacity, leading to a reduced number of
neuroblasts and neurons, but also of astrocytes. CB1 itself does
not alter directly the cell fate of adult NSCs.
These results are corroborated by using another genetic
approach, in which we injected a lentivirus containing a Sox-2
promoter-driven Cre recombinase (Sox2-Cre) into the DG of
ROSA26-ﬂoxed-stop-YFP mice crossed with ﬂoxed CB1 animals
(Fig. 4A). Due to activity of Sox-2 promoter in NSCs, CB1 was
knocked-out in NSCs, and YFP was expressed. At 23 days post
infection (dpi), BrdU was injected to quantify the proliferation
at 28 dpi and the differentiation at 56 dpi (Fig. 4B). Injection of
Sox2-Cre lentivirus led to expression of YFP in adult NSCs and
their progeny in the SGZ of the DG in both CB1wt/wt and Sox2-
CB1ko/ko mice and to BrdU labeled dividing cells (Fig. 4C). YFP/
BrdU-positive cells were reduced (P = 0.039) in Sox2-CB1ko/ko
mice (289 ± 82 cells) 28 dpi as compared to CB1wt/wt mice
(686 ± 103 cells). (Fig. 4D). At 56 dpi, YFP/BrdU cells were also
decreased in Sox2-CB1ko/ko mice (53 ± 10 cells) as compared to
CB1wt/wt mice (108 ± 18 cells), but not signiﬁcantly (P = 0.06).
Furthermore, we were interested in investigating the differenti-
ation potential of targeted cells, using co-localization analysis
of YFP-positive cells with either the astrocytic marker S100b or
the neuronal marker NeuN (Fig. 4E). Quantiﬁcation showed
Figure 5. (A) Timeline showing the experimental paradigm used for retroviral injections into TAM-induced nes-CB1ko/ko and control mice. (B) Representative micro-
graph depicting recombined YFP cells and retrovirally-labeled RFP newborn neurons in the hippocampus in CB1wt/wt and nes-CB1ko/ko mice. (C) Maximum intensity
projection of a three-dimensionally traced neuron in CB1wt/wt and nes-CB1ko/ko animals. (D) Histogram showing signiﬁcantly reduced dendritic length of traced
neurons in nes-CB1ko/ko mice as compared to CB1wt/wt control (n = 23 neurons; six animals per genotype); *P < 0.05, two-tailed unpaired Student’s t-test. (E) Sholl
analysis shows no alterations in number of intersections of dendritic arbors. Data represent mean ± SEM. Scale bar, 100 μm. (F) Exemplary micrographs showing den-
dritic ﬁlaments of retrovirally RFP-labeled newborn neurons in CB1wt/wt and nes-CB1ko/ko mice. Scale bar, 2 μm. (G) Graph depicting the quantiﬁcation of protru-
sions in dendritic segments (n = 21 segments; four mice). The density of dendritic spines is expressed as protrusions per micrometer dendritic length; ***P < 0.0001,
two-tailed unpaired Student’s t-test.
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81.0 ± 4.8% being triple positive for YFP/BrdU/NeuN in
CB1wt/wt and 73.5 ± 7.1% in Sox2-CB1ko/ko mice, revealing no
difference between both genotypes (Fig. 4F). In CB1wt/wt, 12.2 ±
1.3% were triple positive for YFP/BrdU/S100b and 14.7 ± 2.8% in
Sox2-CB1ko/ko mice, indicating that differentiation into the
astroglial lineage was not affected.
Dendritic, but not axonal growth is regulated by CB1 in
newborn neurons
To examine if absence of CB1 has an effect on the integration of
adult-born neurons into the existing neural circuitry, we analyzed
the morphology of four-week old neurons. Mice were injected
with a retrovirus transducing RFP on the last day of TAM treat-
ment (Fig. 5A). On 28 dpi, single newborn neurons in the SGZ
were visualized (Fig. 5B), with dendrites extending through the
molecular layer of the DG. Three-dimensional reconstruction of
the dendritic arbor in both CB1wt/wt and nes-CB1ko/ko mice
(Fig. 5C) revealed a signiﬁcantly reduced (P = 0.03) dendritic length
in CB1-deﬁcient neurons (1097 ± 52 μm) as compared to control
neurons (1340 ± 81 μm) (Fig. 5D). To further analyze dendritic
arborization, Sholl analysis was carried out in 4-week-old neu-
rons, which revealed no signiﬁcant differences in dendritic com-
plexity between control and CB1-deﬁcient neurons (Fig. 5E).
However, dendritic spine density was signiﬁcantly reduced in
nes-CB1ko/ko (1.601 ± 0.064 protrusions/μm) as compared to
CB1wt/wt (2.016 ± 0.05631 protrusions/μm) mice (P < 0.0001)
(Fig. 5F and G). In contrast, measurement of axonal length
revealed no difference between CB1wt/wt (1160 ± 34.43 μm, n = 22
sections of injected hemispheres, four mice) and nes-CB1ko/ko
(1096 ± 46.3 μm, n = 17 sections of injected hemispheres, four
mice) mice (Supplementary Fig. 5), pointing towards a CB1-
independent mechanism of regulating axonal length in newborn
hippocampal granule neurons.
Given that diacylglycerol lipase (DAGL), the major 2-AG syn-
thesizing enzyme, and 2-AG signaling play a crucial role in den-
dritic elongation (Oudin, Hobbs, et al. 2011), we tested whether
the observed defects in dendritic growth in nes-CB1ko/ko arise
from a reduced DAGLα and 2-AG signaling. To this end, we
FACS-isolated two distinct SGZ subpopulations, namely CD133+
neural stem cells and PSA-NCAM+ newborn neurons, in both
genotypes and analyzed DAGLα expression by RT/qPCR. We did
not detect a genotype difference in CD133+ neural stem cells
and, most importantly, neither in PSA-NCAM+ newborn neu-
rons (Supplementary Fig. 6). Interestingly, we found a
genotype-independent, 3-fold upregulation of DAGLα in PSA-
NCAM+ cells as compared to CD133+ neural stem cells.
To ﬁgure out more potential dysregulated candidate genes,
which had been implicated in progenitor proliferation and neur-
ite growth and could therefore account for the defects seen in
nes-CB1ko/ko mice, we performed RT/qPCR experiments of DG
neurospheres from both genotypes and found that BDNF mRNA
levels were decreased in nes-CB1ko/ko (Supplementary Fig. 7).
We furthermore addressed the question whether other compo-
nents of the endocannabinoid system were dysregulated. In fact,
CB2 mRNA levels were found to be reduced in nes-CB1ko/ko
(Supplementary Fig. 7).
CB1 is required for neurogenesis-dependent LTP in the
hippocampus
Adult neurogenesis involves incorporation of new neurons in
the existing neural circuitry. Since we manipulated the prolifer-
ation potential of newborn neurons and the number of
neuroblasts and neurons, a potential impact of CB1 deletion on
circuit properties, including synaptic plasticity, was investi-
gated. Speciﬁcally, we analyzed the development of long-term
potentiation (LTP) induced by theta burst stimulation (TBS) at
two hippocampal synapses: medial perforant path to dentate
gyrus (MPP-DG) and CA3 to CA1 (CA3-CA1).
To study the potentiation of adult born granule cells, we ﬁrst
investigated LTP at the MPP-DG synapse in the presence of pic-
rotoxin, a GABA-A receptor antagonist. In these conditions (i.e.,
in the presence of picrotoxin), LTP was indistinguishable
between the two groups (Fig. 6A and C), suggesting that CB1
deletion does not change potentiation of adult granule neu-
rons. New neurons in the DG have been shown to undergo a
form of LTP, which requires the activation of NR2b subunit-
containing NMDA receptors (Snyder et al. 2001). After TBS at
MPP-DG synapses in the absence of picrotoxin, control mice
displayed a potentiation lasting for 60min, which was blocked
when the NR2b antagonist ifenprodil was applied. In contrast,
the level of potentiation in nes-CB1ko/ko mice was lower than
in control mice, and the potentiation exhibited a decay similar
to that observed in slices from control mice after incubation
with ifenprodil (Fig. 6B). Averaged potentiation levels of the last
5min displayed signiﬁcantly different fEPSP slopes in nes-
CB1ko/ko (103.5 ± 2.4%, P = 0.007) and CB1wt/wt+ifenprodil
(99.4 ± 2.2%, P = 0.008) mice as compared to CB1wt/wt mice
(120.1 ± 3.1%) (Fig. 6D).
To further analyze physiological changes in synaptic plastic-
ity in the hippocampus of nes-CB1ko/ko mice, we stimulated
Schaffer collaterals of CA3 by TBS and recorded fEPSPs in CA1,
which resulted in an LTP that was signiﬁcantly different from
that of wild-type controls (Fig. 6E). Averaged potentiation levels
of the last 5min of LTP recording displayed signiﬁcant different
(P = 0.042) fEPSP slopes in nes-CB1ko/ko (132.47 ± 2.04%) mice
as compared to CB1wt/wt mice (141.01 ± 2.98%) (Fig. 6F).
Baseline synaptic transmission in these LTP experiments
was evaluated by testing input-output responses, and short-
term plasticity was also tested by paired-pulse-paradigm
(Supplementary Fig. 8). Basal synaptic properties in the DG
were unaltered between the three groups (wt/wt; CB1ko/ko; wt/
wt+ifenprodil) when slices were treated with picrotoxin
(Supplementary Fig. 8A). Untreated slices from nes-CB1ko/ko
animals showed signiﬁcant alterations at ﬁber volley ampli-
tudes between 0.3 and 0.5mV (0.3mV: P = 0.034, 0.4mV: P =
0.039, 0.5mV: P = 0.025, Supplementary Fig. 8B, middle panel).
In the CA1 region, analysis of input-output strength revealed
signiﬁcant alterations between groups at ﬁber volley ampli-
tudes between 0.4 and 0.8mV (0.4mV: P = 0.032, 0.5mV: P =
0.039, 0.6mV: P = 0.006, 0.7mV: P = 0.003, 0.8mV: P = 0.011,
Supplementary Fig. 8 C, middle panel).
All together, these results show that CB1 deletion from pro-
liferating cells in the dentate gyrus can result in alterations in
LTP both within and outside the DG (MPP-DG and CA3-CA1).
Spatial memory and behavioral despair are regulated
by CB1 in adult-born neurons
We next tested the animals in emotion- and memory-related
hippocampus-dependent behavioral tasks, which have been
implicated to be inﬂuenced by newly born neurons (Anacker
and Hen 2017).
Mice were tested on 28 dptm (Fig. 7A), starting with the spa-
tial object recognition test in a Y-maze. Here, nes-CB1ko/ko
mice showed a signiﬁcant decrease (P = 0.038) in the index of
recognition (CB1wt/wt: 61.1 ± 2.1%, nes-CB1ko/ko: 52.9 ± 3.4%),
CB1 receptor in adult neurogenesis Zimmermann et al. | 11
D
ow
nloaded from
 https://academ
ic.oup.com
/cercor/advance-article-abstract/doi/10.1093/cercor/bhy258/5126794 by guest on 15 O
ctober 2018
while total exploration time and distance moved were unal-
tered (Fig. 7B). The reduced index of recognition implies that
deletion of CB1 from NSCs deteriorates cognitive performance.
When testing animals in the Morris water maze (MWM) test,
both groups were equally able to ﬁnd the visible platform.
During training with the hidden platform, nes-CB1ko/ko mice
Figure 6. Summary plots of the ﬁeld EPSP (fEPSP) slope elicited in response to a test stimulus before (-20 to 0min) and after (0 to 60min) tetanic stimulation of the
medial perforant path (MPP) in (A) nes-CB1ko/ko (n = 8 slices, two animals) and in CB1wt/wt (n = 9 slices, three animals) in presence of picrotoxin, 28 to 42 dptm, and
(B) in nes-CB1ko/ko (n = 12 slices, four animals) and in CB1wt/wt in absence (n = 11 slices, four animals) or presence (n = 8 slices, three animals) of ifenprodil, 28 to 42
dptm. (C, D) Averaged potentiation levels during the last 5minutes of LTP in the conditions depicted in A and B respectively. **P < 0.01, one-way ANOVA. (E) fEPSPs
were recorded in CA1 region by stimulating Schaffer collateral axons of area CA3. Acute slices of nes-CB1ko/ko mice (n = 16 slices, four animals) displayed an LTP
curve that is signiﬁcantly different to that of littermate controls (n = 23 slices, ﬁve animals). (F) Averaged potentiation levels during the last 5minutes of LTP are sig-
niﬁcantly lower in nes-CB1ko/ko than in CB1wt/wt mice, *P < 0.05, two-tailed unpaired Student’s t-test, t = 2.102. Data are represented as mean ± SEM.
12 | Cerebral Cortex
D
ow
nloaded from
 https://academ
ic.oup.com
/cercor/advance-article-abstract/doi/10.1093/cercor/bhy258/5126794 by guest on 15 O
ctober 2018
displayed higher escape latencies (P = 0.036) over the time
course of 8 days, indicating that CB1 deletion leads to impaired
learning acquisition of spatial cues. However, during the probe
trial, all animals spent the same amount of time in the target
quadrant (CB1wt/wt: 28.5 ± 1.5 s, nes-CB1ko/ko: 27.9 ± 2.4 s),
suggesting that ﬁnally the spatial engram was memorized the
same in the two genotypes (Fig. 7C).
As it is known that the process of adult neurogenesis regu-
lates behavioral despair, animals were analyzed in the forced
swim test, which has been used as a test to assess depressive-
like behavior or efﬁcacy of antidepressant drugs. Animals lack-
ing CB1 displayed an increase (P = 0.031) in immobility time
(nes-CB1ko/ko: 141.0 ± 6.7 s; CB1wt/wt: 115.2 ± 8.2 s) and a
decrease (P = 0.017) in latency to ﬁrst immobility (nes-CB1ko/ko:
32.5 ± 2.9 s; CB1wt/wt: 52.1 ± 6.0 s) (Fig. 7D). In contrast, CB1 dele-
tion did not affect body weight, locomotion, nor anxiety-like
behavior in the open ﬁeld and light dark test (Supplementary
Fig. 9A-C).
In conclusion, CB1-induced impairments on the cellular
level led to a signiﬁcant deterioration in spatial learning and
memory, as well as to an enhancement of behavioral despair.
Discussion
A central question in the ﬁeld of adult neurogenesis is how the
multitude of signals in the neurogenic niche regulates NSC
fate. It has been known that endocannabinoids regulate adult
neurogenesis as part of the niche signals, by acting in an auto-
crine and/or paracrine fashion on the cannabinoid receptors
CB1 and CB2 (Prenderville et al. 2015). However, it has remained
elusive, whether cannabinoid receptor signaling acts directly
via its expression in NSCs and its progeny (Aguado et al. 2006;
Palazuelos et al. 2006) or whether receptor signaling works indi-
rectly via niche-surrounding cells, which by themselves pro-
duce signaling molecules or alter neurotransmitter release. The
present study addressed the regulation of adult neurogenesis
Figure 7. (A) Behavior of CB1wt/wt and nes-CB1ko/ko mice was analyzed at 28 dptm. (B) nes-CB1ko/ko mice in the spatial object recognition test displayed a decrease
in the index of recognition, whereas total exploration and total distance traveled were not impaired. N = 19 (CB1wt/wt), n = 13 (nes-CB1ko/ko), *P < 0.05, two-tailed
unpaired Student’s t-test. (C) Animals in the Morris water maze test exhibited no genotype difference in escape latency during visible platform trainings. Nes-CB1ko/
ko mice showed a decreased performance in Morris water maze training during the days hidden platform search; n = 20 (CB1wt/wt), n = 19 (nes-CB1ko/ko), *P < 0.05,
repeated measure 2-way ANOVA; Bonferroni post-test, F = 4.74. After 8 days of training, both genotypes spent the same time in the target quadrant (TQ) during the
probe trial. TR, target right; TO, target opposite; TL, target left. (D) nes-CB1ko/ko mice displayed an increase in immobility time and a decrease in latency to ﬁrst
immobility in the forced swim test. N = 19 (CB1wt/wt), n = 13 (nes-CB1ko/ko), *P < 0.05, two-tailed unpaired Student’s t-test. Graphs show mean ± SEM.
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by studying the direct function of NSC lineage-speciﬁc CB1 in
the adult mouse dentate gyrus in vivo. To this end, we devel-
oped a transgenic strategy to conditionally inactivate CB1 in
adult NSCs and their progeny, and investigated the direct role
of CB1 on adult neurogenesis, electrophysiological properties of
newborn neurons, and neurogenesis-related behavior.
Selective deletion of CB1 from nestin-positive cells led to a
decrease in total adult-born cells in the DG, caused by a reduc-
tion in NSC/NPC proliferation, without affecting apoptosis of
newly generated cells. However, survival defects due to the
caspase-independent form of programmed cell-death ferropto-
sis cannot be excluded. As the proliferation marker BrdU is pre-
dicted to interfere with the cell cycle and therefore could lead
to changes in cellular fate (Duque and Rakic 2011), we backed
up our observation using genetic labeling with YFP. The
observed defect in proliferation was additionally supported by
a second approach targeting Sox2-positive NSCs with a lentivir-
al vector. Our data demonstrate that the reduction in NSC/NPC
proliferation, which was previously shown in complete CB1
knock-out animals (Aguado et al. 2006), is caused by the loss of
CB1 expressed directly in NSCs and not in surrounding cells,
e.g., glutamatergic Mossy cells and GABAergic interneurons in
close proximity. Interestingly, the proliferation rate of recom-
bined cells in the SVZ was unchanged between CB1wt/wt and
nes-CB1ko/ko animals, which accounts for a region-speciﬁc
effect of CB1 on NSC/NPC proliferation in the adult. Even if
adult NSCs and progenitors in the DG and SVZ share some cel-
lular characteristics reﬂected by the expression of common
speciﬁc transcription factors, they are clearly of different
embryonic origin (Fuentealba et al. 2015; Berg et al. 2018) and
are equipped with distinct transcriptional proﬁles (Hsieh 2012).
These features may explain that the regulative effect of CB1 on
proliferation is exerted only in DG NSCs/NPCs. Additionally, dif-
ferences in ligand availability in both neurogenic niches could
account for the observed differences.
2-AG signaling was proposed to be functional in neural stem
cells in an autocrine manner (Oudin, Hobbs, et al. 2011). Our
data provide hints that 2-AG levels in the hippocampal neuro-
genic niche did not depend on CB1 expressed in NSC, as we
detected no genotype differences in DAGLα mRNA levels in
FACS-isolated CD133+ neural stem cells. Thus, there appears no
crosstalk between CB1 signaling and DAGLα expression. This
implicates that CB1 is necessary for proper NSC/NPC prolifera-
tion, even in the presence functional 2-AG. On the other hand,
2-AG signaling is also indispensable, as other works showed
deteriorated adult neurogenesis caused by reduced prolifera-
tion in DAGLα and DAGLβ knock-out mice (Gao et al. 2010) or by
pharmacological blockade of DAGL (Goncalves et al. 2008).
The activation of CB1 via endocannabinoid signaling in
NSCs/NPCs might involve the proliferative signal transduction
pathways PI3K/Akt and ERK (Galve-Roperh et al. 2002), two
classical pathways which promote cell survival and prolifera-
tion. Downstream targets, in turn, may include mTORC1 and
CREB, which are central regulators of immediate early genes,
such as c-fos, c-jun, zif268, and BDNF, leading to neural cell
survival/death decisions (Prenderville et al. 2015) or NSC prolif-
eration (Li et al. 2008). Indeed, we found a reduction of BDNF
mRNA in DG neurospheres of animals lacking CB1 in NSCs/
NPCs. Furthermore, we detected a downregulation of CB2. To
our knowledge, there are no published data describing a direct
regulation of CB1 on CB2 expression. However, other groups
have shown an increase of adult NSC/NPC proliferation rate
when using the selective CB2 agonist HU-308 (Palazuelos et al.
2006). Additionally, CB1 might interact with growth factors by
transactivating e.g., the EGF receptor (Hart et al. 2004) or the
major BDNF receptor TrkB (Berghuis et al. 2005). Even though
proliferation was reduced, we did not detect a lineage switch in
the differentiation potential of CB1-deﬁcient NSCs. This points
towards a non-cell autonomous effect of CB1 on differentiation
when compared to the results of Aguado and colleagues
(Aguado et al. 2006), who showed a deﬁcit in hippocampal
astrogliogenesis in complete CB1 knock-out mice. In that work,
CB1 deletion on cells other than NSCs inside the niche may
have indirectly increased neurogenesis or reduced astroglio-
genesis; e.g., CB1 acting on glutamatergic or GABAergic neurons
and on astrocytes. Regardless of an unchanged differentiation
potential in our study, we detected a reduced number of astro-
cytes, neuroblasts and mature granule cells as a consequence
of reduced proliferation at early stages of neurogenesis.
The observation that independent of the genotype, the pool
of YFP-positive neurons increased from 28 dptm to 56 dptm
whereas the population of YFP-positive astrocytes decreased,
could be explained by the fact that the differentiated progeny
derives from distinct NSC types. Neuronal cells are derived
from fast dividing intermediate progenitors (type-2 cells),
which increase the pool of initially recombined cells in a short
amount of time. Furthermore, the development of mature
NeuN-positive neurons approximately takes around two month
(~56 days) (Zhao et al. 2008), explaining why the majority of
NeuN-positive recombined cells is observed at 56 dptm. In con-
trast, astrocytes derive from more quiescent nestin-positive
radial glia-like cells (type-1 cells) (Bonaguidi et al. 2011; Encinas
et al. 2011; Berg et al. 2018), explaining why we did not detect
an increase in recombined astrocytic cells four weeks after. A
decrease instead could be explained by the fact that initially
more type-2 than type-1 cells had recombined and that during
tissue homeostasis dying astrocytes later were replenished
from initially non-recombined cells. Furthermore, recombina-
tion in resident nestin re-expressing astrocytes cannot be
excluded, which then also could be renewed from non-
recombined progenitors.
Stereological counts revealed that 12 000–15 000 newly gener-
ated cells were targeted in wild-type mice (concordant with Lagace
et al. 2007), representing 2.4–3% of the total DG granule cell popula-
tion (500,000 cells (Ihunwo and Schliebs 2010)). Reduction of neuro-
genesis in nes-CB1ko/ko mice led to 8 000–11 000 cells, constituting
only 1.6–2.2% of total cells. In electrophysiological experiments,
NSC-speciﬁc CB1 deletion revealed an impairment of LTP in the
DG and in pyramidal neurons of the CA1 region. The latter could
be the result of circuit remodeling induced by potential changes of
mossy ﬁber-LTP which might have induced structural changes/
connectivity in CA3 and ﬁnally downstream changes in Schaffer-
collateral LTP. Furthermore, we showed that loss of CB1 signaling
led to a speciﬁc form of strongly impaired LTP in young neurons,
comparable to LTP observed in ifenprodil-treated slices from
CB1wt/wt mice. Glutamatergic signaling in mature granule neu-
rons was not affected by CB1 deletion, as shown by experiments
where GABAergic inhibition in the DG was blocked with picrotoxin.
Our data are in concert with a study showing that blocked hippo-
campal neurogenesis by irradiation led to the same reduced
ifenprodil-sensitive LTP at MPP-DG synapses (Snyder et al. 2001).
However, in addition to the reduced number of newborn neurons,
impaired LTP formation could also result from a reduced dendritic
arborization pattern. Indeed, our data showed that CB1-deﬁcient
newborn neurons displayed a reduction in dendritic length and
spine density, but had no defect in axonal growth, indicating that
CB1 is required for proper dendritic maturation of adult-born neu-
rons originating from NSCs in the SGZ. It has previously been
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shown that CB1 has an impact on neuronal and synaptic matura-
tion via regulating growth cone motility and neuritogenesis during
embryonic development (Williams et al. 2003; Berghuis et al. 2007;
Watson et al. 2008). Furthermore, autocrine and paracrine
endocannabinoid-signaling regulates migration of SVZ-derived
neuroblasts in the postnatal brain by CB1 and DAGLα, which are
co-expressed in growth cones (Oudin, Gajendra, et al. 2011). As we
detected no inhibition of axonal growth on newborn neurons
devoid of CB1, our data support the possibility that axonal elonga-
tion of newborn hippocampal neurons is differently regulated as
compared to neuroblast migration in the adult SVZ. DAGLα, which
is required for axonal growth during development and for retro-
grade synaptic signaling at mature synapses with high dendritic
expression levels, has been postulated to function as a “dendrite
initiation factor” by postsynaptic production of 2-AG (Bisogno et al.
2003; Reisenberg et al. 2012). For this reason, we analyzed whether
the impaired dendritic growth could be related to a decreased
DAGLα expression in newborn neurons, caused by the lack of CB1
signaling. However, we found that deterioration of dendritic
growth was 2-AG-independent, as DAGLα expression was not
altered in FACS-isolated PSA-NCAM+ newborn neurons and
CD133+ stem cells isolated from wildtype and NSC-speciﬁc CB1
knock-out mice. The data pinpoint again to a clear necessity of
CB1 in proper dendritic growth, despite unaltered availability of 2-
AG. Interestingly, DAGLα mRNA was signiﬁcantly increased in
developing newborn neurons compared to stem cells. These data
ﬁt with work from Jung et al. (2011), showing an increase of DAGL
during RA-induced differentiation of Neuro2A cells. However, our
results are in conﬂict with observations on differentiating the neu-
ral stem cell line Cor-1 (Walker et al. 2010). The difference could be
explained by the fact that the latter cell line gives rise to
GABAergic interneurons, which in their mature state do not
express DAGLα anymore (Berghuis et al. 2007), but mature DG
granule neurons originating from newborn hippocampal PSA-
NCAM+ cells do (Sugaya et al. 2016).
In addition to the predominantly presynaptic expression of
CB1, postsynaptic localization has also been demonstrated (Njoo
et al. 2015; Maroso et al. 2016). Even if we have not tested
whether maturing granule neurons display postsynaptic CB1,
this scenario could likely account for the dendritic defects seen
in the progeny of CB1-deﬁcient NSCs. Alternatively, earlier sig-
naling events at the level of NSCs or neuroblasts may already
determine dendritic length. Signaling cascades could involve
BDNF as a potent regulator of dendritic outgrowth (Tolwani et al.
2002), which has been shown to act via autocrine signaling in
adult born granule cells (Wang et al. 2015). However, BDNF also
positively regulates dendritic arbor complexity, which was not
affected in our study. It is known that distinct molecules regulate
outgrowth and branching (Jan and Jan 2010). For this reason,
direct CB1 signaling in neuroblasts or maturing granule neurons
could trigger gene expression of only outgrowth-related proteins.
In addition to reduced LTP at the MPP-DG synapses, we also
found a small but signiﬁcant decrease of LTP even in the CA1
ﬁeld in the mutant mice, revealing functional alterations
beyond the CB1-deﬁciency in the MPP-DG path. These results
indicate that the ability of the DG to continuously add new
granule cells may exert surprisingly long-range effects on
downstream circuits (Song et al. 2012).
A decrease in adult neurogenesis has been shown to inﬂu-
ence cognitive performance and mood regulation (Fanselow
and Dong 2010; Anacker and Hen 2017). When we tested nes-
CB1ko/ko mice in neurogenesis-related behavioral paradigms,
hippocampus-dependent spatial learning was affected and
depressive-like behavior was induced. Nes-CB1ko/ko mice
exhibited a marked decrease in spatial learning in the Morris
water maze, which is consistent with data from other studies
where the number of newborn cells was reduced (Goncalves
et al. 2016). Furthermore, we showed that nes-CB1ko/ko mice
exhibit deterioration of cognitive performance and of innate
preference for novelty in another hippocampus-dependent
test, the spatial object recognition test. This test requires the
hippocampus for encoding, consolidation, and retrieval, and
assesses short-term spatial memory in the mouse. Our results
are in accordance with another study addressing adult neuro-
genesis and cognition, which showed that the amount of neu-
roblasts was positively correlated to the reaction to novelty
(van Dijk et al. 2016). Functional studies and computational
modeling of the effects of adult neurogenesis on hippocampal
function have generated different theories for the role of new-
born neurons (Goncalves et al. 2016). These include the forma-
tion of temporal and spatial associations in memory (Aimone
et al. 2006; Becker and Wojtowicz 2007) and cognitive ﬂexibility
during learning of new tasks (Chambers et al. 2004) as well as
balancing pattern separation/integration (Aimone et al. 2009).
Furthermore, functional adult neurogenesis has been impli-
cated in the pathophysiology of major depression. A signiﬁcant
subpopulation of patients with major depression was shown to
have a reduced hippocampal volume potentially due to
decreased neurogenesis, and these patients displayed cognitive
deﬁcits (Goncalves et al. 2016). In addition, antidepressant
treatment leads to clinical improvement associated with a
slow, temporal increase in adult hippocampal neurogenesis
(Miller and Hen 2015). However, more data are needed to deter-
mine whether a neurogenic decline is causative or associative
with the occurrence of major depression. In the present study,
nes-CB1ko/ko mice displayed an increase in behavioral despair
in the forced swim test. Presumably, the pattern of hypoproli-
feration in nes-CB1-deﬁcient mice in this study is similar to
alterations in neurogenesis during depression, suggesting that
a neurogenic failure could lead to depressive-like behavior.
Altogether, our data underline the importance of functional
neurogenesis in the adult mouse DG, which serves as a major
input region to the hippocampus and, therefore, is thought to
play a key role in learning, memory and spatial navigation
tasks. Furthermore, our data indicate the necessity of func-
tional adult neurogenesis to serve as a reservoir for stress resil-
ience and vulnerability in neuropsychiatric disorders (Levone
et al. 2015). Here, we showed that ablating intrinsic signaling of
NSC-resident CB1 is sufﬁcient to lead to detrimental effects at
the structural, physiological and behavioral level in adult mice.
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Supplementary material is available at Cerebral Cortex online.
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